1. Heavy Chain Only Antibodies: A New Paradigm in Personalized HER2+ Breast Cancer Therapy

S. Moein Moghimi*, Fatemeh Rahbarizadeh, Davoud Ahmadvand, Ladan Parhamifar

Bioimpacts. 2013;3(1): 1-4. doi: 10.5681/bi.2013.009

PMCID: PMC3648910 PMID: 23678463 Scopus ID: 84879192201

Article

PDF

XML

Cited By:

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate (2024): 20%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar; SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of COPE
Follower of ICMJE
Permission: Creative Commons